We are live on
!
Find out more
Kymera Therapeutics
KYMR
KYMR
254 hedge funds and large institutions have $6.99B invested in Kymera Therapeutics in 2025 Q4 according to their latest regulatory filings, with 68 funds opening new positions, 97 increasing their positions, 64 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
325% more first-time investments, than exits
New positions opened: 68 | Existing positions closed: 16
53% more capital invested
Capital invested by funds: $4.58B → $6.99B (+$2.41B)
52% more repeat investments, than reductions
Existing positions increased: 97 | Existing positions reduced: 64
21% more funds holding
Funds holding: 210 → 254 (+44)
11.78% more ownership
Funds ownership: 113.1% → 124.88% (+12%)
8% more funds holding in top 10
Funds holding in top 10: 12 → 13 (+1)
41% less call options, than puts
Call options by funds: $9.18M | Put options by funds: $15.6M
Holders
254
Holders Change
+44
Holders Change %
+20.95%
% of All Funds
3.09%
Holding in Top 10
13
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+8.33%
% of All Funds
0.16%
New
68
Increased
97
Reduced
64
Closed
16
Calls
$9.18M
Puts
$15.6M
Net Calls
-$6.45M
Net Calls Change
-$12M
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$206M |
| 2 |
BBA
Baker Bros. Advisors
New York
|
+$135M |
| 3 |
ACA
Avoro Capital Advisors
New York
|
+$76M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$71.7M |
| 5 |
AllianceBernstein
Nashville,
Tennessee
|
+$61M |
Top Sellers
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$52.9M |
| 2 |
Jennison Associates
New York
|
-$35.9M |
| 3 |
AIIC
AJU IB Investment Company
Seoul,
South Korea
|
-$29.5M |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$21.7M |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
-$16.4M |
